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Abstract
Background: Chikungunya virus (CHIKV) re-emerged in Sri Lanka in late 2006 after a 40-year hiatus. We sought to
identify and characterize acute chikungunya infection (CHIK) in patients presenting with acute undifferentiated febrile
illness in unstudied rural and semi-urban southern Sri Lanka in 2007.
Methodology/Principal Findings: We enrolled febrile patients ≥ 2 years of age, collected uniform epidemiologic and
clinical data, and obtained serum samples for serology, virus isolation, and real-time reverse-transcriptase PCR (RT-
PCR). Serology on paired acute and convalescent samples identified acute chikungunya infection in 3.5% (28/797)
patients without acute dengue virus (DENV) infection, 64.3% (18/28) of which were confirmed by viral isolation and/or
real-time RT-PCR. No CHIKV/DENV co-infections were detected among 54 patients with confirmed acute DENV.
Sequencing of the E1 coding region of six temporally distinct CHIKV isolates (April through October 2007) showed
that all isolates posessed the E1-226A residue and were most closely related to Sri Lankan and Indian isolates from
the same time period. Except for more frequent and persistent musculoskeletal symptoms, acute chikungunya
infections mimicked DENV and other acute febrile illnesses. Only 12/797 (1.5%) patients had serological evidence of
past chikungunya infection.
Conclusions/Significance: Our findings suggest CHIKV is a prominent cause of non-specific acute febrile illness in
southern Sri Lanka.
Citation: Reller ME, Akoroda U, Nagahawatte A, Devasiri V, Kodikaarachchi W, et al. (2013) Chikungunya as a Cause of Acute Febrile Illness in Southern
Sri Lanka. PLoS ONE 8(12): e82259. doi:10.1371/journal.pone.0082259
Editor: Lark L. Coffey, University of California Davis, United States of America
Received July 4, 2013; Accepted October 21, 2013; Published December 2, 2013
Copyright: © 2013 Reller et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Patient enrollment was supported by the Hubert-Yeargan Center for Global Health and the Duke University Medical Center Chancellor’s Tsunami
Relief Fund. Dr. MER was supported by a Johns Hopkins Center for Global Health Junior Faculty Grant, a Clinician Scientist Career Development Award
from Johns Hopkins School of Medicine, and the National Institute of Allergy and Infectious Diseases, National Institutes of Health (K23AIO83931). All
laboratory testing was done at the Duke-NUS Graduate Medical School and was supported by the Duke‐NUS Signature Research Program funded by the
Agency for Science, Technology and Research (A*STAR), Singapore, and the Ministry of Health, Singapore, and by funding from the US Navy Medical
Research Unit #2 in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
* E-mail: mreller1@jhmi.edu
Introduction
Chikungunya is caused by infection with chikungunya virus
(CHIKV), a mosquito-transmitted Alphavirus, family
Togaviridae, found in tropical and subtropical regions of Africa,
the Indian Ocean islands, and south and southeast Asia [1].
First recognized in Tanzania in 1953, chikungunya, which
translates as “to be contorted” or “that which bends up,” is
characterized by fever and musculoskeletal pain, and hence
mimics dengue fever and other acute febrile illnesses. In Africa
the virus is enzootic and is thought to be maintained in a
sylvatic cyle involving primates and forest Aedes species [1]. In
Asia CHIKV largely causes urban epidemics and circulates
between humans and mosquitos (primarily Aedes aegypti, but
also Ae. albopictus); recent evidence suggests it may also
have a sylvatic cycle in Malaysia [2].
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Epidemic CHIKV was recognized again in the Indian
subcontinent in 2005, first in India and then in neighboring Sri
Lanka (population ~ 20 million) in November 2006 [3]. After a
40-year hiatus [4], >37,000 suspected cases of CHIKV were
reported in densely-populated regions in the north, east, and
western coastal belt of Sri Lanka in 2007 and a similar number
in 2008 [5,6]. Intrinsic limitations in diagnosis, limited resources
for surveillance, and a concurrent dengue virus (DENV)
epidemic delayed recognition and characterization of the
CHIKV outbreak. In a community-based study in the Central
Province during this period, in which patients with strongly
suspected CHIKV or DENV were enrolled, Kularatne and
colleagues found arthritis to be indicative of chikungunya
(present in 57% [12/23] with chikungunya versus no one [0/21]
with dengue); further, all with arthritis developed chronic
sequelae [5].
To investigate and characterize CHIKV as a cause of acute
febrile illness in unstudied rural and semi-urban southern Sri
Lanka and to compare it with dengue, we prospectively
enrolled patients ≥2 years of age with undifferentiated fever
who presented to a large public hospital. We obtained
epidemiological and clinical data and samples for paired
serology and real-time reverse-transcriptase PCR (RT-PCR).
Methods
Setting and patients
We recruited patients in the emergency department, acute
care clinics, and adult and pediatric wards of Teaching Hospital
Karapitiya (THK), southern Sri Lanka’s largest (1300-bed)
hospital, located in the seaport city of Galle. Febrile (>38°C
tympanic) patients >2 years of age without trauma or
hospitalization within the previous 7 days were eligible for
enrollment. Study doctors verified eligibility and willingness to
return for a 2-4 week convalescent follow-up visit and obtained
written consent from patients (>18 years) or parents (<18
years) and assent if ≥12 -17 years. Study personnel recorded
epidemiologic and clinical data obtained at enrollment on a
standardized form. Study doctors obtained blood for on-site
clinician-requested testing and off-site diagnostic testing.
Patients returned for clinical and serologic follow-up 2 to 4
weeks later, or if unable to return and address was known,
were visited in their home.
Samples
Serum samples were stored promptly at -80°C. Samples
were shipped on dry ice to the University of North Carolina at
Chapel Hill School of Medicine to identify acute DENV
infections [7] and then to the Duke-NUS Graduate Medical
School Singapore, Program in Emerging Infectious Diseases to
diagnose acute CHIKV infections.
Testing for CHIKV
Serum samples were tested for CHIKV IgG by initially
screening convalescent sera at a dilution of 1:32 by indirect
immunofluenscence (IFA); those positive were rescreened at
1:64. If positive at 1:64, acute and convalescent sera were
tested concurrently and serially diluted in phosplate-buffered
saline to titer to endpoint. Acute-phase serum from patients
with acute CHIKV were processed for virus isolation and RT-
PCR.
IgG IFA for CHIKV
CHIKV stock (Ross strain) was grown in baby hamster
kidney cells (BHK-21, ATCC CCL-10), harvested, and used to
spot 12-well Teflon coated slides. After drying, slides were
fixed in cold acetone for 10 minutes, air dried, and stored at
-20°C. Diluted patient sera along with negative and positive
controls were added (20 ul) to each slide well, incubated at
37°C for 45 minutes, rinsed once with 1X PBS, immersed in 1
xPBS for 5 minutes, and air dried. Twenty µl of FITC-
conjugated anti-human IgG antibody with 0.1% Evans Blue
were added to each well, incubated at 37°C for 45 min, rinsed
in PBS, and a cover glass mounted. The slides were examined
using a fluorescent microscope.
Serologic interpretation
We considered an IgG titer of 64 as definitive evidence of
CHIKV infection. We defined acute CHIKV infection as a 4-fold
or greater rise in IgG titer, including in those with
seroconversion (i.e. acute-sample titer 16 and convalescent
sample-titer ≥ 64). We defined past CHIKV infection as stable
(i.e. no change), <4-fold rise, or decreasing IgG titers.
Real-time reverse-transcriptase PCR for CHIKV
RNA was extracted from acute-phase serum of patients with
serologically confirmed acute CHIKV infection using the
QIAamp Viral RNA Mini kit (QIAGEN, Hilden, Germany)
according to manufacturer’s instructions.  Reverse transcription
was performed using Invitrogen Superscript III First Strand
Synthesis System (Life Technologies, Carlsbad, CA),
according to manufacturer’s instructions.  Real time-RT-PCR
using the LightCycler 480 SYBR Green I Master kit (Roche
Diagnostics, Penzberg, Germany) and primers described
elsewhere [8] was performed under the following conditions:
95°C for 10 seconds, 55°C for 5 seconds, and 72°C for 10
seconds for 45 cycles before melt curve analysis.  If a clear
melting peak for CHIKV (between 85.1°C and 85.7°C) was not
observed, the sample was subjected to electrophoresis on a
1.5% agarose gel. A positive control derived from cultured
CHIKV was included in the run. A sample displaying an
amplification profile within 40 cycles of amplification and
bearing similarity to the peak profile of the positive control was
considered as positive for CHIKV. Negative controls were
included for the reverse transcriptase and real time-RT-PCR
steps. 
Isolation of CHIKV
Virus isolation was done by in-vitro inoculation of C6/36 Ae.
albopictus cells adapted to a higher temperature to increase
virus replication and reduce the incubation period[9]. Acute
serum from all confirmed acute cases were diluted 1:10 in L-15
(Gibco, Life TechnologiesTM, Carlsbad, CA, USA) maintenance
medium and 200 uL was inoculated onto a confluent monolayer
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of C6/36 cells. After adsorption for 1 hour at 37°C, the inoculum
was removed and fresh medium added. The cells were then
incubated at 30°C until cytopathic effects were observed or up
to 10 days, whichever was earlier. Viruses were identified by
using the culture supernatant for RNA extraction followed by
cDNA synthesis and RT-PCR using primers specific for CHIKV.
Sequencing of the E1 coding region of CHIKV
CHIKV RNA extracted from the virus isolation culture
supernatants of 6 patients (2 each enrolled early, mid, and late
during the study) was sequenced. The culture supernatant was
collected and centrifuged at 2000 rpm for 10 minutes to remove
cell debris. Viral RNA was extracted from the supernatant with
a QIAamp Viral RNA Mini Kit (QIAGEN, Valencia, CA, USA)
according to the manufacturer’s protocol and stored at -80°C
until use. Reverse transcription with random hexamers to yield
cDNA was performed with Invitrogen Superscript III First
Strand Synthesis System (Life Technologies, Carlsbad, CA),
according to manufacturer's instructions. CHIKV structural
genes were amplified with the following primer pairs:
CHIKV-34F and CHIKV-39R, CHIKV-36F and CHIKV-41R,
CHIKV-40F and CHIKV-45R, CHIKV-44F and CHIKV-49R,
CHIKV-46F and CHIKV-49R. All primer sequences are listed in
Table S1. CHIKV RT-PCR products were excised from a 1%
preparative agarose gel and extracted with the Qiagen
Qiaquick Gel Extraction Kit. RT-PCR products were sequenced
with the same forward and reverse primers used for
amplification. The resulting sequences are deposited in
GenBank with the accession numbers KF578457-KF578462.
Consensus sequences were then compared to the published
E1 sequences [10,11]. Multiple sequence alignment of the Sri
Lankan CHIKV E1 sequences to other CHIKV sequences
deposited in GenBank was carried out using a fast Fourier
transform in MAFFT [12]. The maximum-likelihood
phylogenetic tree was inferred from the sequence alignment
using RAxML [13,14]. The robustness of the maximum-
likelihood tree was assessed by 1000 maximum-likelihood
bootstrap replications. The maximum-likelihood tree was
visualized and produced using FigTree v1.4.0 [15].
Statistical Analysis
Proportions were compared using the chi-square test or
Fisher’s exact test and continuous variables using ANOVA if
normally distributed and Kruskal-Wallis rank sum test if not
normally distributed. Analyses were done with Stata IC 11.0
(StataCorp, College Station, TX).
Ethics Statement
Written consent, and assent when appropriate, was obtained
from all participants. The institutional review boards of Ruhuna
University (Sri Lanka), Johns Hopkins University, and Duke
University Medical Center approved the study.
Results
Febrile cohort
Paired sera to identify acute CHIKV infections in those
without acute DENVwere available from 797/1079 (73.9%)
patients consecutively enrolled between February and
November 2007. Those for whom paired sera were available
did not differ by age (p=0.33), sex (p=0.10), or level of
education (p=0.09) from others. Most participants (90.2%)
reported rural residence, a greater proportion of whom returned
for follow-up than urban dwellers (75.0% vs. 62.9%, p=0.007).
Among these 797 patients, most were male (60.7%), and the
median age (30.8 years [intraquartile range, IQR 19, 48]) did
not differ by sex (p=0.89). Many (35.6%) febrile patients
reported having taken an antibiotic for their illness before
presentation. The reported duration of fever and of illness
before presentation was similar (p=0.66 and p=0.34,
respectively) in those with and without follow-up. The median
time between the acute visit and convalescent follow-up was
21 days (IQR 15, 33).
Acute CHIKV infection
We identified acute CHIKV infection in 3.5% (28/797) of our
febrile cohort, and no CHIKV/DENV co-infections amongst 54
patients with acute DENV described previously [7]. Twenty-six
acute CHIKV infections were associated with both a ≥4-fold
rise in titer and seroconversion. The age distribution of patients
with and without acute CHIKV infection is shown in Figure 1.
Cases of acute CHIKV infection occurred during each month of
the study, accounting for 1.0% of acute febrile illnesses during
June but 10.9% in October (Figure 2). Although there was not a
clear monsoon season in 2007 and rainfall was inconsistent
(mean 301 mm, range 36 to 657), acute chikungunga infection
was more common (p=0.003) in months with more rain (64.3%
of cases during typical monsoon months of July to October)
than in drier months (35.7% of cases March to June).
A large proportion of patients with acute CHIKV infection
reported taking antibiotics before presentation as did other
febrile patients (8 [40%] vs. 201 [35.5%], respectively, p=0.68).
Patients with acute CHIKV were more likely (92.9% vs. 70.7%,
p=0.01) than those with other febrile illnesses to be admitted to
hospital, but the duration of hospitalization tended to be shorter
(median 3 days [IQR 2,4] versus 4 days [IQR 3,6], p=0.06).
Presumptive clinical diagnosis on presentation was available
for 734, including all 28 with acute CHIKV infection. Notably,
none of these 28 were initially suspected to have acute CHIKV
infection; presumptive diagnoses included non-specific viral
syndrome (17), leptospirosis (6), DENV (1), hepatitis (1),
infective endocarditis (1), meningitis (1), and gastroenteritis (1).
Specified discharge clinical diagnoses (available for 6 patients)
included non-specific viral syndrome (2), leptospirosis (1),
leptospirosis and CHIKV infection (1), DENV (1), and systemic
lupus erythematosus (1).
Acute CHIKV infection vs. DENV vs. other acute febrile
illness (AFI)
Acute DENV infection in this febrile cohort has been detailed
elsewhere (54 patients with DENV confirmed by ELISA,
Chikungunya in Southern Sri Lanka
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neutralization, isolation, and RT-PCR with acute primary and
secondary DENV found to be similar) [7]. Clinical features
associated with acute CHIKV infection vs. acute DENV vs.
other AFI are shown in Table 1. This 3-way comparison was
chosen because comparing acute CHIKV with other AFI
including DENV (2-way comparison) yielded similar results,
there were no CHIKV/DENV co-infections, and clinical
differentiation of the two has been difficult.
Patients with acute CHIKV infection and other AFI reported a
slightly shorter duration of febrile illness (both 3 days) than did
patients with DENV (4 days, p=0.05). Patients with acute
CHIKV infection were older (all but one patient ≥18 years of
age, p=0.02) and more likely to be male (82% versus 60-69%
with DENV or other AFI). Muscle pain and joint pain were
common symptoms (82% and 71%, respectively) in those with
acute CHIKV, and more frequent than in patients with DENV or
other AFI (p<0.001 and p=0.009, respectively). Those with
acute CHIKV were as likely to report headache as those with
DENV or other AFI (all ≥ 75%), but much less likely to report
cough (15% CHIKV vs. 35% DENV vs. 60% other AFI,
p<0.001). On examination, conjunctivitis and rash were
uncommon features (36% and 11%, respectively), but more
often present in those with acute CHIKV vs. those with DENV
or other AFI (p=0.001 and p=0.02, respectively). Those with
CHIKV had lower white blood cell (including neutrophil and
lymphocyte subsets) and platelet counts (p=0.002 and 0.0001,
respectively) than those with DENV or other AFI. The
unadjusted odds of joint pain and of muscle pain in those with
acute CHIKV infection vs. non-dengue AFI were 5.1 (95% CI
1.9-13.6) and 3.3 (95% CI 1.4-7.5), respectively; the
unadjusted odds of musculoskeletal symptoms were increased
in those with acute CHIKV even relative to acute DENV [joint
pain OR 2.4 (95% confidence interval 0.9-6.4) and muscle pain
OR 3.4 (95% confidence interval 1.1-10.3)]. Although most
patients reported resolution of symptoms at follow-up, patients
with acute CHIKV infection were more likely than patients with
DENV or other AFI to report persistent muscle and joint pain at
the convalescent (range 12- 45 days after acute visit) visit
(11% vs. 8% vs. 2%, p=0.003 and 14% vs. 4% vs. 3%,
p=0.002, respectively).
Past CHIKV infection
Only 12 (1.5%) patients were found to have serologic
evidence of past CHIKV infection. Acute and convalescent
Figure 1.  Age distribution of patients with and without acute chikungunya infection, southern Sri Lanka, 2007.  
doi: 10.1371/journal.pone.0082259.g001
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titers were relatively low (64 and 64, respectively, in 7 patients,
32 and 64 in 3 patients, 128 and 64 in 1 patient, and 128 and
128 in 1 patient). The age distribution of those with serologic
evidence of past CHIKV infection is shown in Figure 3. The
demographic characteristics of the 40 patients with acute or
past CHIKV infection vs. no evidence of CHIKV infection are
detailed in Table 2. Those with evidence of past CHIKV
infection were older than those with acute infection, and both
were older than those with no evidence of CHIKV infection
(median age 49 years [IQR 21-57] vs. 41 [IQR 29-51] vs. 30
[IQR 19-48], respectively, p =0.05). Similarly, the proportion
that were male varied significantly among the groups (75% vs.
82% vs. 60%, p=0.03). Although uncommon, urban residence
was reported more frequently in those with acute or past
CHIKV infection vs. those with no evidence of CHIKV
infection(17.5% vs. 7.9%, p=0.03).
Confirmation of acute CHIKV infection
We isolated virus from 10 of 28 (35.7%) patients with acute
CHIKV infection, including 7 of 15 (73.3%) with seroconversion
and convalescent titer of 64 versus 1 of 11 (9.1%) with
seroconversion and convalescent titer ≥128. Duration of illness
and fever before presentation were similar in viremic and non-
viremic individuals. Samples were RT-PCR-positive in 18/28
(64.3%) of patients with acute CHIKV infection, including all 10
from whom virus was isolated (p=0.004). Those in whom virus
was identified by RT-PCR reported shorter durations of fever
before presentation than RT-PCR-negative patients (mean
2.6+/- 1.0 vs. mean 3.7+/-1.6 days, p=0.04).
Phylogenetic analysis of Sri Lankan CHIKV isolates
The structural coding region of six CHIKV isolates obtained
from April to October 2007 (GenBank numbers KF578457-
KF578462) were sequenced and compared to other CHIKV
sequences deposited in GenBank [6,8,10,11,16]. Phylogenetic
analysis shows that the newly sequenced Sri Lankan isolates
belonged to the clade that contained viruses isolated from
Reunion Islands (2005), Sri Lanka (2007, 2008) and India
(2007) (Orange and Pink in Figure 4) with strong bootstrap
support (100%) [6,8,10,11,16]. These viruses were distantly
related to viruses previously isolated from the Indian
subcontinent and SE Asia during 1975–2000 (Blue in Figure 4)
and other lineages previously isolated from West Africa during
1975–2000 (Green in Figure 4), highlighting the introduction of
a divergent CHIKV lineage to the Indian subcontinent during
2007 [6,8,10,11,16]. Within the new subcontinental lineage, the
2007–2008 Sri Lankan and Indian isolates formed a
monophyletic lineage (89% bootstrap support) indicating a
common source for these viruses, whereas the 2005 Reunion
isolates formed an outlying relationship to the sub-continental
strains. These results suggest that the CHIKV that caused the
2007–2008 outbreaks in India and Sri Lanka were most likely
derived from Reunion/2005-like isolates.
Comparison of amino acid sequence alignments surrounding
the E1-226 region for our 6 CHIKV isolates and others from
elsewhere in Sri Lanka (Central and Western Province) and
India (Figure 5) supports the results obtained through
phylogenetic analysis. The isolates we sequenced shared on
average 99.69% (standard deviation [SD] 0.22%), 99.71% (SD
Figure 2.  Distribution of febrile patients with and without acute chikungunya infection by month, southern Sri Lanka,
2007.  
doi: 10.1371/journal.pone.0082259.g002
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0.14%), and 99.65% (SD 0.22%) identity to Sri Lankan clusters
A, B, and C, respectively, as described by Hapuarachi et al [6].
 These isolates were slightly less similar to the Indian and
Reunion Island isolates (99.52% [SD 0.3%] and 99.51% [SD
Table 1. Clinical characteristics of febrile patients with
acute chikungunya vs. acute dengue vs. other acute febrile













Age in years, median
(IQR) 41 (29, 51) 28 (22, 45) 31 (19, 48) 0.14
Adult (≥ 18 years) 96% 89% 79% 0.02
Male 82% 69% 60% 0.04
Days ill, median
(IQR) 3.0 (2.0, 3.5) 4.0 (2.0, 5.0) 3.0 (2.0, 7.0) 0.05
Days fever, median
(IQR) 3.0 (2.0, 3.0) 4.0 (3.0, 7.0) 3.0 (2.0, 5.0) 0.17
Prior antibiotic
treatment 40% 50% 35% 0.16
Admitted to hospital 93% 93% 71% <0.001
Symptom     
Headache 75% 76% 78% 0.87
Sore throat 18% 13% 29% 0.02
Cough 15% 35% 60% <0.001
Dyspnea 11% 15% 17% 0.64
Lethargy 52% 69% 67% 0.25
Joint pain 71% 51% 43% 0.009
Muscle pain 82% 58% 47% 0.001
Abdominal pain 11% 25% 19% 0.30
Vomiting 32% 43% 37% 0.56
Diarrhea 18% 22% 10% 0.02
Sign     
Conjunctival
infection 36% 28% 13% <0.001
Pharyngeal exudate 7% 6% 14% 0.11
Lymphadenopathy 18% 4% 24% 0.002
Jaundice 0% 8% 1% 0.004
Lung crackles 4% 6% 14% 0.058
Tender abdomen 7% 19% 9% 0.08
Hepatomegaly 4% 11% 5% 0.14
Rash 11%† 6% 2% 0.007
Arthritis 0% 2% 0.5% 0.40
Laboratory
parameter     




















256) 190 (156, 242) 234 (190, 297) 0.0001
0.17%], respectively) and lacked the E1-A226V mutation of the
latter [6,10]. This E1-A226V was shown to increase the ability
of CHIKV to propagate in Aedes albopictus and has been
implicated in the explosive spread of CHIKV on the Indian
Ocean islands and Indian subcontinent [6,10,11,17].
Discussion
We sought to document whether CHIKV was an important
cause of non-specific acute febrile illness in southern Sri Lanka
in 2007 and to describe its epidemiological, clinical, and
virologic features. We identified the E1-226A strain of CHIKV in
southern Sri Lanka in 2007 rather than the E1-A226V strain
found in 2008 [6]. This is consistent with other studies from
elsewhere in Sri Lanka during the same time period [6]. The
CHIKV isolates we sequenced appeared to be most closely
related to the Sri Lankan CHIKV clusters A, B and C and those
from India isolates described by Hapuarachi et al, and more
distantly related to the Reunion Island isolates [6,11].
The small (5.0%) proportion of patients with serologic
evidence of acute or past CHIKV infection compared with that
of DENV (54%) [7] suggests the more recent emergence of
CHIKV in southern Sri Lanka, and is consistent with a
retrospective serosurvey conducted in Sri Lanka’s Central
Province [18]. The finding that most (26/28) acute infections
were associated with seroconversion and that all but one
patient was ≥18 years old also suggests a population lacking
immunity to CHIKV. The finding that males were more likely to
Table 1 (continued).
WBC, White blood count per μl; ANC, Absolute neutrophil count per μl; ALC,
Absolute lymphocyte count per μl; IQR, interquartile range; SD, standard deviation;
Hemoglobin, g/dL; Platelets, x1000/μl †1 urticaria, 1 eschar *Kruskal-Wallis test for
proportions and skewed continuous variables; analysis of variance test: normally
distributed continuous variables.
doi: 10.1371/journal.pone.0082259.t001
Figure 3.  Presence of anti-chikungunya IgG by age
(years) in febrile patients, southern Sri Lanka, 2007.  
doi: 10.1371/journal.pone.0082259.g003
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have acute CHIKV may reflect more time outdoors; however, it
is unclear why more a greater proportion of those with acute
CHIKV than acute DENV were male, since both share the
same vector.
We describe a milder spectrum of symptomatic CHIKV
infection than the epidemic disease reported from sites in the
Indian Ocean with mutated virus (E1-A226V). For example,
patients in our study had arthralgia but not arthritis, whereas
arthritis has been an important feature of E1-A226V-associated
epidemic disease [19]. Although milder disease could be
explained by a less virulent virus (E1-A226), it may also be
related to other factors, such as our enrollment of unselected
febrile patients to identify unsuspected CHIKV infections that
closely mimicked DENV and other febrile illnesses [7,20].
Severe disease [5] was reported elsewhere in Sri Lanka during
the same period that was likely also caused by E1-A226, since
E1-A226V appeared in Sri Lanka in 2008 [6]. However,
selective recruitment and diagnostic uncertainty (e.g., IgM is
less specific than paired IgG) confounds comparison of disease
severity in Kularatne’s 2006-2007 cohort versus our Sri Lankan
cohort. Our findings emphasize the challenges of clinical
diagnosis, particularly in unselected patients with recent onset
Table 2. Demographic characteristics of febrile patients
with serologic evidence of acute or past chikungunya
infection vs. no serologic evidence of chikungunya,





Age in years, median
(IQR) 41.6 (27.8-51.8) 30.3 (18.5-47.7) 0.01
Male 80.0 59.7 0.01
Residence   0.03
Rural 82.5 92.1  
Urban 17.5 7.9  
Type of Work   0.01
Home 23.1 26.9  
Laborer 28.2 25.3  
Farmer, e.g. rice paddy 2.6 2.7  
Merchant 10.3 2.7  
Student 5.1 23.1  
Other 30.8 19.3  
Swim/Bathe/Wade   0.93
None 76.9 74.2  
River 10.3 13.0  
Paddy Field 10.3 10.2  
Pond/Lake 0 1.1  
Other 2.6 1.6  
Water Source   0.05
Tap 50.0 29.5  
Boiled 7.5 9.6  
Well 42.5 60.3  
Other 0.0 0.7  
*. Except for median age, data are percentages. IQR, intraquartile range
†. Kruskal-Wallis test to compare proportions across groups.
doi: 10.1371/journal.pone.0082259.t002
fever and illness (median 3 days) in the absence of a
recognized local epidemic. Clinical acumen is also difficult to
hone when confirmatory testing is not available, which
highlights the need for affordable, accurate point-of-care
diagnostic tests [21].
Clinical features suggestive of acute CHIKV infection in our
study included almost universal arthralgia and/or myalgia,
which was more common and more likely to be persistent even
relative to those with acute DENV infection as has been noted
by others [16,22,23]. We also found conjunctivitis and rash to
be more frequent in those with CHIKV versus DENV [24]..
Arthritis was not observed, in contrast to what was found by
Kularatne and others as well as reports from the Indian Ocean
[5,19,25]. In our febrile cohort of predominantly adults, patients
with acute CHIKV infection also presented earlier in illness than
patients with DENV, were older, and were disproportionately
male. Most studies have included either adults [23] or children
[26] but not both. In Tanzania, where children and adults were
enrolled in equal proportions, CHIKV was more common in
children, which differs from our findings [27]. However, in this
study, in which patients were also enrolled with undifferentiated
fever, unsuspected acute CHIKV infection and relatively mild
illness were also observed [27]. Of note, in Tanzania, acute
CHIKV infections occurred more often during dry months and
only hepatomegaly and absence of vomiting were associated
clinical features. However, other studies with different
enrollment criteria (including patients living in tropical countries
as well as travelers) have reported acute onset or shorter
duration of illness [28], older age [5,23,29], arthritis and/or
arthralgia [5,24,28,30], conjunctivitis [31], and rash [24,26,28]
to be suggestive of acute CHIKV infection rather than DENV or
other acute febrile illness. In contrast, male predominance
[5,23,28] and the occurence and degree of leukopenia [32],
including lymphopenia, and thrombocytopenia [24,26,30] have
been more variable findings.
Strengths of our study include reproducible and objective
enrollment criteria (documented fever of defined magnitude)
and use of gold standard diagnostic criteria (paired IgG
serology by IFA) made possible by a high proportion (80%) in
whom convalescent clinical and serological follow-up was
achieved. Convalescent serological follow-up is important,
since acute-phase IgM depends critically on the timing of
sample collection (insensitive early in acute infection and non-
specific during convalescence) and some assays have been
found to be unreliable [33]. Our study also highlights the
continued role of paired serology, since neither real-time RT-
PCR nor direct viral isolation were able to detect all paired
sera-confirmed acute CHIKV infections. Paired serology
provides only indirect evidence of infection. However, the
proportion additionally confirmed by other methods (35.7% by
virus isolation and 64.3% by RT-PCR), the association
between RT-PCR positivity and shorter duration of illness
before presentation, and the improved sensitivity of RT-PCR
vs. viral isolation are all consistent with other reports and the
known duration (4-7 days) of CHIKV viremia [22,31].
Sequencing to identify circulation of E1-226A CHIKV in
southern Sri Lanka in 2007 extends the understanding of the
molecular epidemiology of the virus. Finally, we sought but did
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not find patients co-infected with both CHIKV and DENV,
although co-infections could plausibly occur from the bite of a
dually-infected Aedes spp. mosquito and have been reported
[3,34].
We were not able to describe the full clinical spectrum of
acute CHIKV infection, which would require a large population-
based study to capture asymptomatic and minimally
symptomatic infections. Since all patients enrolled had fever,
we could not have detected “pure arthralgic” (no fever) or
“unusual” (neither fever nor arthralgias) forms of CHIKV , which
a study in Gabon found in 12.6% and 2.2% cases of confirmed
CHIK, respectively [32]. Sample size may have limited our
ability to detect a difference in median age and intraquartile
range between patients with acute CHIKV infection versus
DENV; however, that a greater proportion with acute CHIKV
were >18 years suggests that those with CHIKV were older.
We did not have the statistical power to contrast clinical
features in different age groups, since despite efforts we
achieved limited enrollment of children. These limitations
notwithstanding, we do describe clinically significant illness in a
large cohort in whom selection bias was unlikely (public
hospital to which all social strata have access). Further,
asymptomatic acute infections are relatively rare (3-25%) with
CHIKV compared with DENV [1]. Our estimate of acute and
past infections may be conservative. Confirmation of cases by
viral isolation and RT-PCR make it unlikely that the cases
Figure 4.  Phylogenetic relationship of Sri Lankan chikungunya virus (CHIKV) isolates.  Sequences corresponding to the
CHIKV structural genes from the six Sri Lankan isolates were compared to published CHIKV sequences [6,8,10,11,16]. Region of
isolation is indicated by text color: West Africa (Red), Asia (Blue), East/South/Central Africa (Green), Reunion Island (Pink) and
India/Sri Lanka (Orange). Isolates from the current study are indicated in bold-italics.
doi: 10.1371/journal.pone.0082259.g004
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Figure 5.  Alignment of the amino acid sequence
surrounding the chikungunya virus E1-226 region.  Amino
acid sequence corresponding to the E1 gene was translated
from the nucleotide sequences of the three Sri Lankan isolates
and compared the amino acid sequences of the isolates
described in Schuffennecker et al 2006, PLoS Med and Kumar
et al 2008, JGV [10,11]. Position E1-226 is highlighted (E1-226
corresponds to position 1035 in the polyprotein).
doi: 10.1371/journal.pone.0082259.g005
described were due to cross-reacting alphaviruses. However,
we cannot exclude the co-circulation of other strains of CHIKV,
since we did not perform sequencing on all isolates. In
screening convalescent sera at a 1:32 dilution for anti-CHIKV
antibody before testing paired sera, we may have missed a
small number of patients with low-titer infections. Additionally,
rescreening or testing sera at a lower dilution may have
identified a few additional low-titer positives. It is unlikely that
we missed past infections (low-titer antibody in the acute
sample but not the convalescent sample), since it is unlikely
that genuine antibody would be lost in 2-4 weeks.
In conclusion, we describe the epidemiology and clinical
features of acute CHIKV infection associated with wild-type
(E1-226A) CHIKV compared with acute DENV and other acute
febrile illness in a prospective cohort of febrile patients in
southern Sri Lanka. Greater awareness of acute CHIKV
infection and the availability of reliable and affordable
diagnostic tests to diagnose acute infection are needed in Sri
Lanka and elsewhere. Countries in other regions are also at
risk [24,35], since outbreaks of DENV, also transmitted by
Aedes mosquitos, have occurred in both the United States and
Europe in the past decade, and one outbreak of acute
chikingunya infection in a temperate region has already
occurred [31].
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